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cense. httpAbstract Objective: To investigate the causes of groin recurrence in patients with vulval cancer
who previously had negative nodes following superﬁcial inguinal node dissection (SIND).
Material and methods: Forty-one patients with squamous cell carcinoma of the vulva (stage I or II)
were operated upon. The primary treatment was wide local excision with 2 cm safety margin and
superﬁcial inguinal lymphadenectomy. Six patients had ipsilateral and one patient had bilateral
groin recurrence. Those patients were subjected to deep inguinal node dissection (one patient
required bilateral node dissection).
Results: The mean age at time of diagnosis was 59 years (range 51–68). The median follow-up per-
iod for all patients was 63 months (range 24–71) and that of the recurrent cases was 20 months
(range 12–38). The mean depth of invasion of the recurrent cases was 5.5 mm (range 5–5.9 mm)
and the mean diameter of the primary tumor in recurrent cases was 3.8 cm (range 3–4.5 cm). All
recurrent cases had a high grade of the primary tumor. The median interval to recurrence was
21 months (range 12–57). The groin recurrence rate after negative SIND was 17% (7/41 patient-
s).The mean number of nodes resected per groin was eight (range 1–17). The nodes ranged in size
from 0.2 to 4.0 cm.
Conclusion: Carcinoma of the vulva with the following criteria (size of tumor is greater than 3 cm,
depth of invasion greater than 5 mm, and high grade tumors) is at high risk of recurrence.
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Surgical management for women with invasive vulvar carci-
noma over the past 30 years has been increasingly more con-
servative, with surgeons seeking to reduce morbidity while
improving survival. Several investigators have described surgi-
cal techniques that reduce the radicality of the primary tumor
resection and the extent of groin dissection [1–3].
In 1979, DiSaia et al. combined some of these innovations
by proposing radical local excision and superﬁcial inguinal
lymph node dissection for selected patients [4]. These authorsational Cancer Institute, Cairo University.
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of the vulva on the basis of their anatomical location. Follow-
ing this report, many gynecologic oncologists limited groin dis-
section to the superﬁcial inguinal lymph nodes only.
Groin relapse in patients who had negative nodes at super-
ﬁcial inguinal lymphadenectomy is uncommon, but, when it
occurs, it carries a very poor prognosis [3]. Several mechanisms
might account for groin relapse following negative superﬁcial
inguinal lymphadenectomy. (a) Presence of micrometastasis
in the superﬁcial inguinal nodes that could be missed by con-
ventional histologic analysis of the resected nodes. (b) Opera-
tive failure is another possibility where superﬁcial nodes that
contain micrometastasis were not resected. (c) Also in transit
tumor emboli in lymphatic channels that are unresected in true
node negative patients have been reported as a possible mech-
anism [5].
The aim of this retrospective study is to investigate the
causes of groin recurrence in patients with early vulvar cancer
who had negative nodes following superﬁcial inguinal node
dissection.
Patients and methods
Forty-one patients with squamous cell carcinoma of the vulva
were operated upon and followed up regularly for a median
period of 63 months (range 24–71 months). Patients who had
clinical and surgical stage I or II disease (clinically N0, and
no inguinal lymph node enlargement according to CT scan
of the region), where the depth of invasion was greater than
1 mm, the primary treatment was consisting of radical wide
excision with 2 cm safety margin and superﬁcial inguinal lym-
phadenectomy as described by DiSaia et al. [4] with multiple
individual modiﬁcations [6]. This is the standard practice at
the author’s institute in stages I and II vulvar carcinoma.
The technique of sentinel lymph node mapping was not per-
formed in these cases.
Superﬁcial inguinal lymphadenectomywas performed. Lym-
phatic-bearing tissue between the superﬁcial (Camper’s) fascia
and the cribriform fascia was removed through a lazy- S inci-
sion. Flaps were created in all directions. Dissection began
distally with division of the saphenous vein. The fat pad with
the saphenous vein was reﬂected superiorly, with the lateral
border of dissection being the lateral margin of the sartorius
muscle. The fat pad from the inguinal ligament was retracted
inferiorly. Dissection over the femoral triangle was done from
lateral to medial. The femoral vessels were not exposed during
the dissection. The junction of the saphenous vein with the fem-
oral vein was identiﬁed and divided. All patients had negative
lymph nodes proved by histopathological examination. Patients
did not receive radiotherapy or chemotherapy. Seven patients
subsequently developed recurrent disease in the groins. The
median time to recurrence was 21 months.
Those seven patients are the focus of this study. They were
investigated by CT scan of the abdomen to exclude liver metas-
tasis or abdominal nodes, CT scan of the pelvis and groin areas
to exclude the presence of iliac nodes and to detect roughly the
state of the femoral vessels, CT scan of the chest to exclude
lung metastasis. Colored Doppler ultrasound was also rou-
tinely done to all recurrent cases to show the patency of the
femoral vessels. The recurrent cases had been subjected to deep
inguinal nodal dissection (1 patient required ilioinguinal nodaldissection due to the presence of associated iliac nodes).
Femoral nerve resection was done in 1 patient. Sartorius mus-
cle transposition was done to protect the vessels after complete
resection in all cases. Two patients required reconstruction of
the skin defect using myocutaneous ﬂaps. Histopathological
study of the resected specimens was done .In addition, more
slides were reviewed from the parafﬁn block of the previously
resected superﬁcial nodes (5 sections from every case) to ex-
clude possibility of missed micrometastasis. The initial patho-
logic diagnosis of the SIND and primary tumor was conﬁrmed
by review of all original hematoxylin and eosin (H&E)-stained
slides regarding the depth of invasion and grade. Two recur-
rent cases received postoperative radiotherapy to the groin as
they had heavy nodal inﬁltration .One patient received postop-
erative chemotherapy due to the presence of iliac and groin
nodes.
Results
The mean age at time of diagnosis was 59 years (range 51–68).
The median follow-up period for all patients was 63 months
(range 24–71) and that of the recurrent cases is 20 months
(range 12–38). The mean depth of invasion of the recurrent
cases was 5.5 mm (range 5–5.9 mm) and the mean diameter
of the primary tumor in recurrent cases was 3.8 cm (range
3–4.5 cm). The mean number of nodes resected per groin was
eight (range 1–17). The nodes ranged in size from 0.2 to
4.0 cm. All the recurrent cases had a high grade of the primary
tumor. The median interval to recurrence was 21 months
(range 12–57). The groin recurrence rate after negative SIND
was 17% (7/41 patients). None of the patients had an associ-
ated recurrence at the primary site of the tumor.
Postoperative specimens showed nodal tissue in 6 patients
and ﬁbroadipose tissue with no nodal material in one patient.
Four patients had nodal recurrence under the cribriform fas-
cia; one of them had ilioinguinal disease. Two patients had
nodal recurrence above and under the cribriform fascia. The
additional H&E-stained slides were reviewed at intermediate
and high-power magniﬁcation. There was no evidence of
micrometastases in the newly sectioned slides or in the initially
diagnosed nodal slides.
Survival; three patients died of distant disease within
12 months, two had intra- abdominal disease and one had
extensive locoregional skin nodules. Three patients have no
evidence of disease at last follow up.
Discussion
Surgical approaches to the inguinal lymph nodes in patients
with vulvar cancer have changed over time. The majority of
patients with early vulvar cancer have negative lymph nodes.
Inguinofemoral lymphadenectomy adopted as the standard
surgical approach at the start of the 20th century is associated
with a high risk of wound break down and lymphoedema.
Modern surgical techniques, antibiotics and closed suction
drainage have reduced the wound complications however the
lymphoedema remains as an essentially untreatable complica-
tion which occur in 25–40% of cases [7].
DiSaia et al. [4] initially reported the modiﬁed inguinal dis-
section to include superﬁcial inguinal lymphadenectomy. Sub-
sequent studies have demonstrated that lymphadenectomy to
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50% [8,9].
To avoid this complication, this technique has being
adopted in our practice in stages I andII vulvar carcinoma.
Follow up of patients having early vulvar cancer and negative
nodes at superﬁcial node dissection in this study showed a
recurrence rate (17%). This ﬁnding is relatively high in com-
parison with other studies [10,11,15]. Kirby et al. [15] reported
an inguinal recurrence rate of 4.6% (3/65 patients) after nega-
tive superﬁcial inguinal lymphadenectomy in stages I and II
vulvar cancer.
Groin relapse in patients who had negative nodes at super-
ﬁcial inguinal lymphadenectomy is uncommon, but when it
occurs it carries a very poor prognosis. Most of the patients
with groin recurrence die of disease [3]. Gershenwald et al.
[12] reported that 80% of patients with groin recurrence in a
negative nodal basin in melanoma patients had associated met-
astatic disease identiﬁed with groin relapse which is not the
case in vulvar carcinoma [15]. More than half of the cases in
this study died of disease progression. This raises the question
about the role of adjuvant chemotherapy and radiotherapy to
such patients. Greater number of patients is needed to specify
the role of adjuvant therapy after groin relapse and to report
about the 5 year and overall survival.
Mary et al. [5] retrospectively studied the causes of groin
relapse in 9 out of 104 patients following negative nodes after
superﬁcial inguinal lymphadenectomy for stages I and II vul-
var cancer. Comprehensive histologic studies did not reveal
evidence of micrometastasis in the selected nodes. An explana-
tion of the causes of relapse may be a micrometastasis in
missed superﬁcial inguinal lymph nodes during lymphadenec-
tomy procedure. This is in contrast to Gershenwald et al.
[12] who investigated the causes of regional nodal failure in
melanoma patients and found that regional nodal recurrence
was the result of occult metastatic disease that was not identi-
ﬁed using conventional histologic evaluation methods. In the
present study, comprehensive retrospective histologic study
of superﬁcial lymphadenectomy specimens of the patients
who experienced inguinal recurrence did not show any micro-
metastasis in the previously resected superﬁcial inguinal lymph
nodes, however, with immunohistochemistry examinations,
the detection of micrometastasis in a previous pN0 node could
be as high as 45% [13]. Our study revealed that groin recur-
rence occurred in tumors having the following criteria (high
grade, diameters larger than 3 cm and depth of invasion more
than 5 mm) and it was not associated with local recurrence.
Patients having tumors with lower criteria experienced no
inguinal recurrence.
Some reports suggested that a wide variety in the published
reports describing different approaches with the same name,
superﬁcial inguinal lymphadenectomy may explain varieties
in groin relapse rate [14]. Our standard technique at SIND
in the present study is to remove nodes above the cribriform
fascia without exposure of the femoral vein. Two patients
had recurrent nodes superﬁcial and deep to the cribriform
fascia, which may be a missed node in the superﬁcial group
that might have given metastasis to the deep group of lymph
nodes. One patient out of seven in this study had a recurrence
in the adipose tissue of the groin which may be due to ﬁeld fail-
ure despite negative nodes. Kirby et al. [15] reported an ingui-
nal recurrence rate of 4.6% (3/65 patients) after negative
superﬁcial inguinal lymphadenectomy in stages I and II vulvarcancer. Univariate and multivariate analysis of the small
sample size did not discover a risk factor as age, lesion size,
and margin status, site of tumor and stage, which was a predic-
tive of recurrence either in the inguinal region or vulva.
To date, there has not been a prospective trial comparing
superﬁcial inguinal lymphadenectomy to inguino-femoral lym-
phadenectomy in patients with early stage vulvar cancer.
Gynecologic Oncology Group (GOG) trial 74 reported groin
relapses in about 5–7% of patients with negative nodes on
superﬁcial inguinal lymph nodes [8] and is now conducting
the largest prospective trial evaluating modiﬁed radical hemi-
vulvectomy and ipsilateral superﬁcial lymphadenectomy pa-
tients compared to historical controls who underwent a
radical en-bloc vulvectomy and bilateral inguinal-femoral
lymphadenectomy.
Conclusion
The causes of groin recurrence after negative SIND are not
deﬁned, however it has been noticed that groin recurrence oc-
curred in tumors having the following criteria (size of tumor is
greater than 3 cm, depth of invasion greater than 5 mm, and
high grade tumors). Further studies on a large number of pa-
tients are needed to investigate the causes and specify the role
of deep inguinal node dissection in tumors with the above
mentioned criteria.
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